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1. Introduction 
Chronic periaortitis is an idiopathic disease whose hallmark is the presence of a fibro-
inflammatory tissue arising from the adventitia of the abdominal aorta and the common 
iliac arteries and extending into the surrounding retroperitoneum and frequently encasing 
neighboring structures such as the ureters and the inferior vena cava (Mitchinson, 1984; 
Parums, 1990). It should be regarded as a generalized disease with three different 
pathophysiological entities, specifically idiopathic retroperitoneal fibrosis, inflammatory 
abdominal aortic aneurysms, and perianeurysmal retroperitoneal fibrosis (Vaglio et al., 
2003; Jois et al., 2004).  
Idiopathic retroperitoneal fibrosis is characterized by periaortic fibroinflammatory tissue, 
which often causes obstruction of the ureters and other adjacent abdominal structures by 
extending into the retroperitoneum (Mitchinson, 1970; Gilkeson & Allen, 1996). A dilated 
aorta is usually not present in idiopathic retroperitoneal fibrosis. Its initial signs and 
symptoms are often nonspecific, such as malaise, anorexia, weight loss, fever, and flank, 
back, or abdominal pain. Inflammatory abdominal aortic aneurysms characteristically 
develop the mass around a dilated aorta, but usually do not cause obstructions (Crawford et 
al., 1985; Pennell et al., 1985). It usually presents with typical symptoms and signs 
characterized by the triad of abdominal or back pain, a pulsatile and sometimes tender 
abdominal mass, and an elevated erythrocyte sedimentation rate. Perianeurysmal 
retroperitoneal fibrosis, which represents a link between these two diagnoses, involves an 
abdominal aortic aneurysms surrounded by fibroinflammatory tissue that encases other 
abdominal organs (Serra et al, 1980).  
These definitions may be a little confusing, and it would probably be more appropriate to 
distinguish aneurysmal from nonaneurysmal forms of chronic periaortitis; idiopathic 
retroperitoneal fibrosis may be referred as non-aneurysmal chronic periaortitis, where as 
inflammatory abdominal aortic aneurysms and perianeurysmal retroperitoneal fibrosis as 
aneurysmal chronic periaortitis (Vaglio et al., 2006). 
It is important to diagnose chronic periaortitis early in its course in order to attempt to 
prevent the severe secondary complication of renal failure due to ureteric obstruction and 
the potentially fatal consequence of aortic rupture (Jois et al., 2004). Although most studies 
have considered these entities separately, these conditions have common clinical and 
histopathologic findings, and thus probably represent different manifestations of the same 
disease. 
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2. Epidemiology 
The prevalence of chronic periaortitis is not well known; the only available epidemiological 
data concern idiopathic retroperitoneal fibrosis and inflammatory abdominal aortic 
aneurysms. Reports from Duke University and the Mayo Clinic estimate that the incidence 
of idiopathic retroperitoneal fibrosis is less than 1 per 10,000 patients (Gilkeson & Allen 
1996). A recent study conducted in Finland on idiopathic retroperitoneal fibrosis has 
demonstrated that its incidence and prevalence are 1/1,000,000 person-year and 1.38 
cases/100,000 inhabitants (Uibu et al., 2004). On the other hand, data regarding the 
incidence of the aneurysmal forms of chronic periaortitis in the whole population are 
lacking, however they represent about 4% to 10% of all abdominal aortic aneurysms 
(Rasmussen et al, 1997; von Fritschen et al., 1999; Yusuf et al., 2007). 
Chronic periaortitis frequently develops in middle-aged adults with a mean age of 
approximately 60 years, but it may also occur in children (Miller et al. 2003; Uibu et al., 2004; 
Vaglio et al., 2006). Men are affected two to three times as often as women and that is even 
more pronounced in the inflammatory abdominal aortic aneurysms (Gilkeson & Allen 1996; 
Uibu et al., 2004; Vaglio et al., 2006). 
There is no evidence of a clear ethnic predisposition or familial clustering, and the disease 
has been reported in twins and siblings only in anecdotal cases (Duffy et al., 1984; Doolin et 
al. 1987). A few studies have addressed the question whether genetic factors may contribute 
to the development of chronic periaortitis. Recent studies have suggested that 
immunogenetic factors may be involved in the pathogenesis of the disease (Rasmussen et 
al., 1997; Martorana et al., 2006).  
A case-control study evaluated the prevalence of HLA alleles in patients with inflammatory 
abdominal aortic aneurysms compared with healthy subjects found that in the inflammatory 
abdominal aortic aneurysms a genetic risk determinant mapping at the HLA-DRB1 locus 
(Rasmussen et al., 1997). Additionally, they identified HLA-DRB1*15 and B1*0404 as 
predisposing alleles.  
Another recent case-control study on patients with chronic periaortitis and healthy controls 
in order to investigate the role of HLA in the susceptibility to chronic periaortitis revealed 
that the frequency of the HLA-DRB1*03 allele was markedly higher in patients with chronic 
periaortitis than in the controls (Martorana et al., 2006). The HLA-DRB1*03 allele is a well-
known marker of autoimmunity, since it is associated with a number of autoimmune 
diseases, which include systemic lupus erythematosus and autoimmune thyroid disease 
(Davidson and Diamond, 2001). Also, the HLA-B*08 allele was significantly associated with 
chronic periaortitis and it is itself linked to a wide range of immune-mediated diseases. 
Furthermore, the comparison of the clinical and laboratory characteristics of HLA-DRB1*03-
positive and HLA-DRB1*03-negative patients showed that the HLA-DRB1*03-positive 
patients with chronic periaortitis have higher acute-phase reactant levels at the time of 
diagnosis (Martorana et al., 2006). These results could imply that the HLA system not only 
confers susceptibility to the development of the disease but also plays a role in the 
modulation of the inflammatory response. 
More recently, CC chemokine receptor 5 (CCR5) gene delta 32 polymorphism has been 
mapped in 100 patients with chronic periaortitis (Boiardi L et al., 2011). The distribution of 
the CCR5 gene delta 32 genotype differed between patients with chronic periaortitis and 
controls (P = 0.01). The CCR5 gene delta 32 allele was more frequent in patients with chronic 
periaortitis [P = 0.02, odds ratio (OR) 2.8 (95% CI 1.2, 6.4)]. Furthermore, CCR5 gene delta 32 
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allele occurred more frequently in patients with inflammatory abdominal aortic aneurysms 
than in patients with idiopathic retroperitoneal fibrosis [P = 0.001, OR 6.4 (95% CI 2.1, 19.1)]. 
The CCR5 gene delta 32 allele frequency was higher in inflammatory abdominal aortic 
aneurysms patients without established atherosclerotic disease compared with controls [66.7 
vs 5.6%, P = 0.00001, OR 34.0 (95% CI 7.4, 156.3)].  
The CC chemokine receptor 5 is expressed on many immune cells, particularly Th1 cells, 
and acts by binding to different chemokines, including RANTES, MIP-1 and MIP-1. The 
CCR5 gene delta 32 polymorphism creates a truncated, nonfunctional receptor and probably 
shifts the immune response toward a Th2 pattern. Interestingly, the association between the 
CCR5 gene delta 32 polymorphism and aneurysmal chronic periaortitis is even stronger in 
patients without overt atherosclerotic disease, which suggests that immune mechanisms 
independent of atherosclerosis play a role in the pathogenesis of chronic periaortitis (Vaglio 
et al., 2011). 
Additionally, environmental and occupational agents have been shown to contribute to 
susceptibility to chronic periaortitis. In a recent study, it has been demonstrated that 
asbestos exposure is associated with a markedly increased risk of developing the chronic 
periaortitis, and smoking is also a significant risk factor (Uibu et al., 2004; Hellmann et al., 
2007). Although smoking is an established risk factor for classical atherosclerotic abdominal 
aortic aneurysms, its frequency is even higher in patients with inflammatory abdominal 
aortic aneurysms (Nitecki et al., 1996; Hellmann et al., 2007). 
3. Pathology 
Chronic periaortitis affects the aortic wall and the surrounding retroperitoneum. The 
classical macroscopic appearance of chronic periaortitis is grossly a whitish and hard 
periaortic mass which extends between the origin of the renal arteries and the bifurcation of 
the common iliac vessels and often distorting medially the ureters but histologically there is 
a continuum of lesions ranging from acute changes to chronic damage (Mitchinson, 1970). 
In the early stages of chronic periaortitis, or in patients with a prominent acute-phase 
reaction, the tissue is highly inflammatory, with numerous lymphocytes, plasma cells, 
macrophages and scattered eosinophils and loose deposits of collagen matrix in thick, 
irregular bands (Mitchinson, 1970; Corradi et al., 2007). In late disease, these aspects evolve, 
either spontaneously or after glucocorticoid therapy, into a relatively acellular fibrous tissue. 
Perivascular involvement of the thoracic aorta is not uncommon, while rarely atypical 
localizations such as peri-duodenal, peri-pancreatic and pelvic sites have also been found 
(Hughes & Buckley, 1993; Corradi et al., 2007).  
Microscopic examination shows signs of active mononuclear cell inflammation in a 
framework of fibrous tissue and fibroblasts (Serra et al, 1980; Gilkeson & Allen, 1996). The 
background of chronic periaortitis consists of varying degrees of fibrosis, characterized by a 
mild-to-moderate and mitotically inactive fibroblasts and myofibroblasts, which are 
immuno-histochemically positive for vimentin and, in the more cellular areas, for -smooth 
muscle actin (Vaglio et al., 2006). The fibrous component is particularly abundant in the late 
stages when the tissue becomes relatively avascular and acellular; its distribution is usually 
diffuse, but sometimes perivascular and perineural.  
The inflammatory infiltrate includes mononuclear cells such as T and B lymphocytes, 
macrophages and plasma cells, although scattered eosinophils can also be found 
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(Mitchinson, 1970). The majority of lymphocytes, macrophages and most vascular 
endothelial cells are HLA-DR-positive. The Ki67 and BerH2 staining is found in B cells and 
T-helper cells, indicating that these cells were proliferating and activated (Meier et al., 2007).  
Two main inflammatory patterns are usually seen, perivascular and diffuse. The 
perivascular aggregates consist mainly of B lymphocytes and a smaller component of 
plasma cells, macrophages, and T lymphocytes, most of which are CD4+ (Corradi et al., 
2007). Sometimes, these follicular aggregates show a germinal center architecture. The 
sclerotic component consists of thick fascicles of type-I collagen, irregularly distributed 
along the lesion; a pathological hallmark is the presence of a regular circumferential fibrous 
bundle surrounding blood vessels and nerves. On the other hand, the diffuse infiltrate has 
an equal percentage of T cells and B cells. Scattered eosinophils are common, whereas 
neutrophils are rare (Mitchinson, 1970; Vaglio et al., 2003). In cases of severe inflammation, 
there may be focal infiltration of the small and medium-sized retroperitoneal vessels, with 
frank vasculitis and fibrinoid necrosis. 
The aortic wall also shows particular changes, such as atherosclerotic degeneration of the 
intima, medial thinning, and marked adventitial inflammation and fibrosis. The composition 
of the inflammatory infiltrate in the aortic wall is similar to the retroperitoneal one, with 
diffuse and perivascular patterns. The adventitial inflammatory infiltrate is often organized in 
lymphoid follicles (Sakata et al., 2008), which are examples of ectopic lymphoneogenesis and 
expression of a highly structured inflammatory or immune-mediated response. Adventitial 
vasa vasorum in aortas of chronic periaortitis show inflammatory infiltration up to frank 
necrotizing vasculitis, endarteritis obliterans, or obliterative phlebitis (Vaglio et al., 2003; 
Sakata et al., 2008). These aortic wall changes are found in all chronic periaortitis disease 
entities, regardless of the presence of aneurysmal dilatation.  
It is interesting to note that autopsy studies have documented the presence of adventitial 
inflammation in aortic sections lacking periaortic fibrosis, which may suggest that aortitis 
could precede the development of adventitial and periadventitial fibrosis (Mitchinson, 
1970). Another autopsy studies have shown that moderate adventitial inflammation and 
fibrosis may not be limited to the abdominal aorta, but may also involve its thoracic aorta 
(Mitchinson, 1972). 
Molecular analysis of aortic biopsies in patients with chronic periaortitis shows gene 
transcripts consistent with lymphocyte activation, such as IFN-, IL-1, IL-2 and IL-4, in 
keeping with the concept that chronic periaortitis is an active inflammatory aortic disease 
(Ramshaw et al., 1994). 
4. Pathogenesis 
Chronic periaortitis is idiopathic in nature, and its pathogenesis remains a matter of debate. 
Initially, it was postulated to represent a local inflammatory reaction to antigens such as 
ceroid and oxidised low-density lipoproteins (LDL), which can be found in the 
atherosclerotic plaques of the abdominal aorta (Parums et al., 1986; Parums et al., 1990; 
Ramshaw & Parums, 1994). Since an intact media constitutes an immunoprivileged site, the 
capacity of lipids deposited in the intima and media to elicit an inflammatory reaction in the 
adventitia may depend on the thinning or breach of the media itself, with consequent transit 
of the lipids. These can be processed by adventitial macrophages and presented to B and T 
cells, thus eliciting a local inflammatory reaction which eventually leads to adventitial and 
peri-aortic inflammation and fibrosis.  
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Morphologic and experimental findings showed that adventitial inflammation also seems to 
be more marked where the media is thinner (Mitchinson, 1972; Mitchinson 1984; Parums et al., 
1990). IgG has been detected in close apposition to extracellular ceroid, and serum antibodies 
to oxidized LDL and ceroid were more common in patients with chronic periaortitis than in 
healthy individuals (Parums et al., 1986; Parums et al., 1990). Furthermore, a wide spectrum of 
adhesion molecules and gene products for cytokines, such as interleukin-1, interleukin-2, 
interleukin-4, and interferon-, have been detected in the aortic adventitia, thus strengthening 
the hypothesis that chronic periaortitis is associated with active adventitial chronic 
inflammation (Ramshaw & Parums, 1994; Ramshaw et al., 1994). 
According to this hypothesis, advanced atherosclerosis is a sine qua non for the development 
of chronic periaortitis, which may be an exaggerated local immune response to plaque 
antigens. The notion that chronic periaortitis is secondary to atherosclerosis is challenged by 
several findings. There was no substantial difference in the incidence of advanced 
atherosclerosis between patients with chronic periaortitis and healthy controls (Uibu et al., 
2004; Breems et al., 2000). Also, chronic periaortitis may affect patients without 
atherosclerosis, and it has been reported in pediatric patients (Miller et al., 2003). A recent 
study showed no significant differences in anti-ox-LDL antibody levels between patients 
with chronic periaortitis and controls (van Bommel et al., 2011). 
Furthermore, a number of findings support the hypothesis that chronic periaortitis may be a 
manifestation of systemic disease rather than the result of a local reaction. These include its 
constitutional symptoms, the high acute-phase reactant levels, autoantibody positivity, and 
the frequent association with other autoimmune diseases (Gilkeson & Allen, 1996; Demko et 
al., 1997; Vaglio et al., 2003; Marcolongo et al., 2004). Additionally, the association with 
HLA-DRB1, a marker of autoimmune diseases, is an additional clue to its autoimmune 
origin (Martorana et al., 2006). 
Chronic periaortitis also has histologic similarities to large vessel vasculitis such as giant cell 
arteritis and Takayasu’s arteritis; prominent adventitial inflammation and the involvement 
of the vasa vasorum (Ramshaw et al., 1994; Vanoli et al., 2005; Vaglio et al., 2006; Salvarani 
et al., 2008), and sometimes extends beyond the abdominal aorta (Mitchinson 1972; Cid et 
al., 1998; Jois et al., 2004). In addition, in some patients with chronic periaortitis the disease 
involves not only the abdominal aorta and the iliac vessels, but also other vascular 
territories such as the thoracic aorta. This finding was already observed long time ago by 
autopsy studies (Mitchinson, 1972). Recently, in a study using 18F-fluorodeoxyglucose 
positron emission tomography, it have also shown that in some patients with chronic 
periaortitis the high 18F-fluorodeoxyglucose uptake in the abdominal aorta and in the 
common iliac arteries coexists with a pathologic uptake in the thoracic aorta and its main 
branches, which confirms the idea that chronic periaortitis is a systemic disease in some 
cases (Salvarani et al., 2005). 
These findings strengthen the idea that chronic periaortitis may originate as a primary 
arteritis involving the aorta. The perivascular- and sometimes transmural-involvement of 
vasa vasorum may represent the initial event of the disease. Its centrifugal extension could 
induce a fibro-inflammatory periaortic reaction, whereas its centripetal spreading could 
promote atherosclerosis, medial thinning and aneurysm formation (Vaglio & Buzio, 2005; 
Vaglio et al., 2006).  
Structural alterations of the aortic wall seen in chronic periaortitis result in part from 
degradation of the macromolecules, such as collagen and elastin. These changes are 
associated with excessive production of matrix metalloproteinases (MMPs), which are 
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assumed to orchestrate the widespread matrix destruction (Freestone et al., 1995). The 
inflammatory infiltrate is thought to play an etiologic role in aneurysm formation by direct 
local production of matrix-degrading enzymes and production of cytokines that induce 
resident mesenchymal cell production of MMPs (Newman et al., 1994). Recent findings 
suggest that both the local mesenchymal cell expression and the macrophage expression of 
MMPs are required for aneurysm formation (Longo et al., 2002).  
Both fibrillar collagen and elastin are highly organized in the lamellar structure of the aortic 
media. One potential mechanism for the complementary role of MMP-2 and MMP-9 is that 
MMP-2 primarily acts as a collagenase-initiating cleavage of the triple helix into one- and 
three-quarter lengths. The single  chains could then be degraded by MMP-9, releasing the 
coiled elastin and causing it to become fattened and attenuated. Rupture and expansion 
rates of abdominal aortic aneurysms have been linked to MMP-2 and MMP-9 levels in tissue 
and plasma (Petersen et al., 2000). Such observations appear consistent with the increased 
medial atrophy observed within inflammatory abdominal aortic aneurysms, because 
activated MMPs may weaken the media by causing destruction of elastic and collagen fibers 
and smooth muscle cells. 
As in many other immune-mediated diseases, environmental and infectious agents probably 
contribute to the pathogenesis of chronic periaortitis. As mentioned above, asbestos 
exposure and smoking are established risk factors (Uibu et al., 2004). It has been 
hypothesized that inflammation within the aortic wall may be a response to infection. Both 
herpes and cytomegalovirus have been described as potential agents (Tanaka et al., 1994). 
Recent interest has been focused on Chlamydia pneumoniae, which was found to be more 
prevalent in aneurysmal than in normal aortic tissue (Tang et al., 2005). 
5. Clinical features 
The clinical presentation of chronic periaortitis is insidious and vague. Lumbar, abdominal 
or flank pain is present in about 80% of the patients. It has been described as insidious, 
persistent and dull, poorly localized, unmodified by movement or rest. If the ureters are 
involved, the pain may be acute and colic-like (Baker et al., 1987; Vaglio et al., 2003; van 
Bommel et al., 2009). During the initial phases, patients may find relief using non-steroidal 
anti-inflammatory drugs, but the beneficial effect of these agents is transient (Gilkeson & 
Allen, 1996; Vaglio et al., 2006). 
In addition to pain, the commonest clinical manifestations are systemic symptoms, most 
likely related to the inflammatory nature of the disease: about 40 to 80% of patients 
complain of fatigue, anorexia, weight loss and low-grade fever (Baker et al., 1987; Kardar et 
al., 2002; Vaglio et al., 2003; Scheel et al., 2009). Ureteral obstruction is the most frequent 
complication of idiopathic retroperitoneal fibrosis. It involves both ureters in a high 
percentage of cases (50–80%) and may occur simultaneously (Kardar et al., 2002; van 
Bommel et al., 2007). Ureteric obstruction is commonly due to edema or inflammation rather 
than fibrosis. This observation is supported by the fact that the obstruction can improve 
rapidly with corticosteroid therapy (Baker et al., 1987; Nitecki et al., 1996).  
In cases of advanced bilateral ureteral obstruction, oliguria and symptoms secondary to 
uremic syndrome occur (Baker et al., 1987; Sterpetti et al., 1989; Jois et al., 2004). Varicocele 
and hydrocele, sometimes associated with testicular pain, are not uncommon, and also 
probably develop because of compression of the gonadal vessels (Baker et al., 1988; Vaglio et 
al., 2003). Constipation and claudication are less common. Lower limb edema and deep 
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venous thrombosis may occur, probably as a result of inferior vena cava and iliac vein 
involvement.  
Physical examination usually reveals abdominal tenderness and sometimes a palpable, 
pulsatile and tender abdominal mass. A periumbilical bruit may be heard in patients with 
inflammatory abdominal aortic aneurysms (Crawford et al., 1985; Nitecki et al., 1996). The 
combination of abdominal pain, a pulsatile mass with overlying bruit, constitutional 
symptoms, and high levels of acute-phase reactants usually distinguish inflammatory 
abdominal aortic aneurysms from noninflammatory abdominal aortic aneurysms. 
Laboratory examinations are useful, but not diagnostic for chronic periaortitis. Acute phase 
reactants such as the erythrocyte sedimentation rate and C-reactive protein are elevated in 
more than 80% of patients with active disease, in keeping with the presence of a systemic 
inflammation and are often used to monitor the clinical course of the disease (Kardar et al., 
2002; Marcolongo et al., 2004; Vaglio et al., 2006). The erythrocyte sedimentation rate and C-
reactive protein dramatically decrease or even normalize after a few weeks of therapy (van 
Bommel et al., 2007), whereas their sensitivity in heralding relapses is uncertain (Vaglio et 
al., 2005). A recent retrospective study investigated whether the erythrocyte sedimentation 
rate and C-reactive protein levels might predict response to glucocorticoid therapy, but 
found that baseline erythrocyte sedimentation rate and C-reactive protein did not 
discriminate between chronic periaortitis patients who experienced disease regression and 
those who showed mass stabilization or progression (Magrey et al., 2009). 
Renal dysfunction is related to the severity of ureteral involvement, but only 18-21% of 
patients actually experiences end-stage renal failure (Baker et al., 1987; Nitecki et al., 1996). 
Normochromic, normocytic anemia is often present as a result of systemic chronic 
inflammation. Leukocytosis, eosinophilia, and polyclonal hypergammaglobulinemia may be 
disclosed in some patients (Gilkeson & Allen, 1996). If polyclonal hypergammaglobulinemia 
is present, it is worthwhile assessing serum immunoglobulin levels and, if available, IgG 
subclasses; IgG4 is high in chronic periaortitis patients with features of IgG4-related 
systemic disease (Vaglio et al, 2011; J.R. Stone, 2011). 
Immunologic and autoimmune tests should always be assessed in patients with chronic 
periaortitis. Antinuclear antibodies have been reported in up to 60% of patients, whereas 
anti-dsDNA and antiextractable nuclear antigen antibodies are rare (Vaglio et al., 2003). 
Rheumatoid factor is not uncommon. The presence of these autoantibodies, although non-
organ-specific and often positive at low titers, may be a clue to an autoimmune origin of 
chronic periaortitis. Alternatively, they may be the earliest manifestation of a smoldering 
disorder that will clinically emerge late in the course of chronic periaortitis.  
On the other hand, certain autoantibodies actually indicate the presence of an associated 
autoimmune disease. When autoimmune thyroiditis coexists, antithyroglobulin and 
antithyroid microsome antibodies are positive (Vaglio et al., 2003). P-antineutrophil and C-
antineutrophil cytoplasmic antibodies have been detected in a few cases of chronic 
periaortitis associated with small vessel vasculitis, such as Wegener granulomatosis and 
microscopic polyangiitis (Kaipiainen-Seppanen et al., 1996; Aslangul et al., 2003). 
6. Evidence of systemic autoimmunity in chronic periaortitis 
Although it has been considered a localized inflammatory disease secondary to 
atherosclerosis, several genetic, clinical, laboratory and pathologic findings suggest that 
chronic periaortitis is a systemic autoimmune disease, perhaps involving a vasculitic process 
of small and medium vessels (Table 1). 
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Autoimmune Component Example 
Genetics Association with HLA-DRB1*03, DRB1*0404, DRB1*15 and 
HLA-B*08 
Association with CC chemokine receptor 5 (CCR5) gene delta 
32 polymorphism 
Autoantibodies Antinuclear antibody 
Anti-thyroid microsome and anti-thyroglobulin antibody 
Anti-neutrophil cytoplasmic antibody 
Rheumatoid factor 
Anti-smooth muscle antibody 
Association with 
Autoimmune diseases 
Autoimmune thyroiditis 
Rapidly progressive glomerulonephritis 
Systemic vasculitis 
Rheumatoid arthritis 
Juvenile rheumatoid arthritis 
Ankylosing spondylitis 
Systemic lupus erythematosus 
Antiphospholipid syndrome 
IgG4-related systemic disease 
Histologic finding Small vessel vasculitis of retroperitoneal vessels and aortic vasa 
vasorum 
Ectopic lymphoid follicles with germinal centers in periaortic 
retroperitoneum and aortic adventitia 
Clinical manifestations Constitutional symptoms, such as fever, fatigue, weight loss, 
anorexia and sleep disturbances 
Systemic involvement of large arteries 
Laboratory findings High erythrocyte sedimentation rate  
High C-reactive protein 
Anemia 
Treatment response Rapid response to corticosteroids 
Prognosis Chronic-relapsing course 
Table 1. Summary of systemic autoimmune components implicated in chronic periaortitis 
6.1 Genetics 
Genetic association study revealed that patients with chronic periaortitis were associated 
with certain genetic markers, which is involved in the immune response and commonly 
associated with autoimmune or inflammatory disease. The HLA system plays a role in 
conferring susceptibility to chronic periaortitis (Rasmussen et al., 1997; Martorana et al., 
2006). The bias in expression of specific HLA alleles are defining features of autoimmune 
disease.  
The HLA-DRB1*03, DRB1*0404, DRB1*15 and HLA-B*08 alleles was significantly higher in 
patients with chronic periaortitis. These alleles are a well-known marker of autoimmunity, 
since it is associated with a number of autoimmune diseases such as systemic lupus 
erythematosus, rheumatoid arthritis, giant cell arteritis, autoimmune thyroiditis, type 1 
diabetes mellitus and myasthenia gravis.  
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The CC chemokine receptor 5 (CCR5) gene delta 32 polymorphism is associated with 
aneurysmal chronic periaortitis, which creates a truncated, nonfunctional receptor and 
probably shifts the immune response toward a Th2 pattern (Boiardi L et al., 2011). 
6.2 Autoantibodies 
Several autoantibodies are positive in varying proportions of patients, which may be a clue 
to an autoimmune origin of chronic periaortitis. Antinuclear antibodies are positive in up to 
50–60% of the cases, although their titer is often low (Vaglio et al., 2003). Anti-thyroid 
microsome and anti-thyroglobulin antibodies may be positive in 25–30% (Martorana et al., 
2006). Other autoantibodies, such as antineutrophil cytoplasmic antibodies, rheumatoid 
factor, and anti-smooth muscle may also be positive.  
6.3 Association with autoimmune disease 
Chronic periaortitis are frequently associated with autoimmune diseases involving other 
organs or structures. Two recent studies have showed a higher incidence of systemic 
autoimmune diseases. A case-control study comparing inflammatory abdominal aortic 
aneurysms and noninflammatory abdominal aortic aneurysms showed a higher incidence of 
systemic autoimmune diseases in the former group (Haug et al., 2003). In another study of 
16 consecutive patients with chronic periaortitis, three had antineutrophil cytoplasmic 
antibody-positive rapid progressive renal disease, three had autoimmune thyroiditis, and 
one had rheumatoid arthritis (Vaglio et al., 2003). 
Another frequently reported association is systemic vasculitides, which in most cases 
involve small and medium-sized vessel vasculitis, such as Wegener granulomatosis and 
polyarteritis nodosa (Akman et al., 1983; Hautekeete et al., 1990; De Roux-Serratrice et al., 
2002) or unclassifiable systemic vasculitis (Hellstrom & Perez-Stable, 1966; Littlejohn & 
Keystone, 1981). Antineutrophil cytoplasmic antibody-associated vasculitic syndromes are 
more and more often reported.  
Chronic periaortitis may frequently be associated with fibroinflammatory disorders 
affecting other organs, IgG4-related systemic disease, which have an autoimmune origin 
(Matsumoto et al., 2008; Ito et al., 2008; Kasashima et al., 2008; Sakata et al., 2008). Other 
rheumatic diseases reported in patients with chronic periaortitis include ankylosing 
spondylitis, juvenile rheumatoid arthritis, systemic lupus erythematosus and 
antiphospholipid syndrome (Leblanc et al., 2002; Tsai et al., 1996; Okada et al., 1999; Kim et 
al., 2010).  
6.4 Histologic findings 
Two peculiar histopathological findings may be interpreted as manifestations of 
autoimmunity. Firstly, about half of patients with chronic periaortitis had adventitial 
inflammation with vasa vasoritis in the small retroperitoneal vessels and the aortic vasa 
vasorum with mononuclear cell infiltration and sometimes fibrinoid necrosis (Mitchinson, 
1970; Vaglio et al., 2003; Lindell et al., 1987). Secondly, the inflammatory infiltrate may be 
organized in lymphoid structures such as lymphoid follicles with germinal centers in both 
periaortic retroperitoneum and aortic adventitia (Ramshaw & Parums, 1994). Ectopic 
lymphoid microstructures with germinal centers have been found in autoimmune disorders, 
such as the synovium in rheumatoid arthritis (Weyand et al., 2001).  
 
Autoimmune Disorders – Pathogenetic Aspects 
 
312 
6.5 Clinical manifestations 
Most patients with chronic periaortitis often complain of constitutional symptoms, such as 
fever, fatigue, weight loss, anorexia and sleep disturbances, which probably reflect the 
systemic inflammatory status (Baker et al., 1987; Vaglio et al., 2003). At least in a subgroup 
of patients, chronic periaortitis is a vasculitis affecting large vessels (Vaglio et al., 2011). 
6.6 Laboratory findings  
Chronic periaortitis usually present with high concentrations of acute-phase reactants such 
as erythrocyte sedimentation rate and C-reactive protein, varying degrees of anemia and, in 
a high percentage of cases, azotemia , which reflect the systemic inflammation (Kardar et al., 
2002; Vaglio et al., 2006). The erythrocyte sedimentation rate and C-reactive protein can also 
be used to monitor the disease course (van Bommel et al., 2007). 
6.7 Treatment response 
The clinical manifestations of chronic periaortitis promptly subside after the initiation of 
glucocorticoids therapy, which again is well in agreement with their inflammatory nature. 
In most patients, they induce remission of the clinical symptoms, normalization of the acute-
phase reactant levels, reduction in size of the retroperitoneal mass and also resolution of the 
obstructive complications (Kardar et al., 2002; Marcolongo et al., 2004; van Bommel et al., 
2007; Magrey et al., 2009). 
However, glucocorticoids have various significant side effects, which sometimes limit their 
prolonged use. The combination of glucocorticoids and immunosuppressants such as 
azathioprine, cyclophosphamide and methotrexate has recently been reported to yield 
favorable results in patients with chronic periaortitis (Marcolongo et al., 2004; Warnatz et al., 
2005). 
6.8 Prognosis 
As is the case in many inflammatory and autoimmune diseases, chronic periaortitis also has 
a chronic-relapsing course. The frequency of relapses may depend on the treatment 
approach, as they occur in 10% to 50% of patients treated with surgery alone and in about 
10% when combined immunosuppressive and surgical therapies are used (Baker et al., 
1988). 
7. IgG4-related systemic disease 
In recent years, numerous studies have reported chronic periaortitis in association with 
IgG4-related systemic disease, a group of autoimmune and fibrosing conditions 
characterized by high serum levels of IgG4 and tissue infiltration by IgG4-bearing plasma 
cells (Vaglio et al, 2011; J.R. Stone, 2011). These conditions share common histopathologic 
characteristics, such as diffuse lymphoplasmacytic infiltration, irregular fibrosis, 
eosinophilic infiltration, and obliterative phlebitis (Neild et al., 2006; Deshpande et al., 2006; 
Masaki et al., 2009).  
7.1 Idiopathic peritoneal fibrosis with IgG4-related systemic disease 
It has become clear that in a subset of patients with idiopathic retroperitoneal fibrosis, the 
disorder is in fact occurring in the setting of IgG4-related systemic disease. For 10 years, 
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there were several reports that autoimmune pancreatitis could be associated with 
inflammatory masses within the retroperitoneum, and it was later recognized that both 
conditions were a manifestation of IgG4-related systemic disease (J.R. Stone, 2011).  
In those reports revealed that the retroperitoneal involvement is typically not entirely 
diffuse, but present primarily as inflammatory masses that often primarily involve the 
abdominal aorta, the kidneys or the ureters (Hamano et al., 2002; Miyajima et al., 2006; 
Tanabe et al., 2006). The inflammatory masses are composed of lymphoplasmacytic 
inflammation and fibrosis with a substantial number of the plasma cells expressing IgG4. 
The nearly all patients revealed an aortic adventitial involvement, even in the absence of 
aortic aneurysm formation. 
In a recent study of retroperitoneal biopsies of patients with idiopathic retroperitoneal 
fibrosis, 10 of 17 cases were felt to be due to IgG-related systemic disease (Zen et al., 2009). 
In these 10 patients, the fraction of plasma cells staining for IgG4 ranged from 35 to 76% 
compared with 0 to 10% for the other seven patients. Furthermore, for the patients with 
IgG4-related disease, the mean serum IgG4 concentration was 695 mg/dl (range 154–2330 
mg/dl) compared with 30 mg/dl (range 10–53 mg/dl) for the other seven patients.  
7.2 Inflammatory abdominal aortic aneurysms with IgG4-related systemic disease 
There are several reports which have indicated that a subset of inflammatory abdominal 
aortic aneurysms cases is in fact a result of IgG4-related systemic disease (Sakata et al., 2008; 
Kasashima et al., 2008; Qian et al., 2009). A recent study comparing 11 cases of inflammatory 
abdominal aortic aneurysms to 12 cases of atherosclerotic abdominal aortic aneurysms and 
demonstrated that the aneurysms defined as inflammatory contained more IgG4+ plasma 
cells than those defined as atherosclerotic. However, in that study there was no clear 
delineation as to which inflammatory aneurysms actually represented involvement by IgG4-
related systemic disease. In addition, the fraction of plasma cells expressing IgG4 was not 
reported for either aneurysms group, making it unclear if the enhanced number of IgG4+ 
plasma cells was simply a manifestation of more plasma cells in general being present in the 
aneurysms labeled as inflammatory. 
There have been several cases reported of inflammatory abdominal aortic aneurysms, which 
were attributed to IgG4-related systemic disease, and which included pathologic evaluation 
of the aorta (Kasashima et al., 2008; Ito et al., 2008; Qian et al., 2009). Pathologically, most 
cases of IgG-4 related inflammatory abdominal aortic aneurysms showed the predominant 
involvement in adventitia with high fraction of IgG4+ infiltrating plasma cells and high 
serum IgG levels (J.R. Stone, 2011). 
Kasashima et al. reported that four of 10 cases (40%) of inflammatory abdominal aortic 
aneurysm were due to IgG4-related systemic disease with prominent IgG4+ plasma cell 
infiltration and high-IgG4 serum levels, whereas the remaining six had a mild (IgG4+ and 
total) plasma cell infiltration. Inflammation was more evident and tissue eosinophilia 
predominated in the IgG4-related inflammatory abdominal aortic aneurysms, whereas some 
degree of neutrophilic infiltration and only rare eosinophils were found in the non-IgG4-
related inflammatory abdominal aortic aneurysms. Because inflammatory aneurysms may 
represent 2–15% of all abdominal aortic aneurysms, this would suggest 1–6% of all 
abdominal aortic aneurysms could be due to IgG4-related inflammatory abdominal aortic 
aneurysms (J.R. Stone, 2011). 
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7.3 Thoracic aortitis with IgG4-related systemic disease 
Until now, the six cases of thoracic aortitis due to IgG4-related systemic disease reported, 
which derived from surgical resections (Khosroshahi et al., 2009; J.H. Stone et al., 2009; 
Ishida et al., 2009; J.H. Stone et al., 2010; Kasashima et al., 2010). All six patients were men in 
an old age (65–74 years). The arch was the most commonly involved in five cases, with two 
cases having involvement of the ascending aorta, and only one case having involvement of 
the descending aorta. Five of the six patients presented with an aneurysm.  
According to histologic assessment, all displayed a prominent lymphoplasmacytic infiltrate, 
with a high percentage of the plasma cells staining for IgG4 (74–89%). In addition, at least 
five patients showed an obstructive phlebitis within the adventitia. In three cases, there was 
a marked predominance for the adventitia compared with the media and intima (J.R. Stone, 
2011). Serum IgG4 level was found to be markedly elevated in 2 patients who tested it and 
both of these patients had documented extra-aortic involvement. 
Assessment of all thoracic aortitis cases surgically resected in a 5-year at one institute 
revealed that IgG4-related systemic disease was responsible for three of four cases of 
lymphoplasmacytic aortitis and 9% of all cases of thoracic aortitis (J.H. Stone et al., 2010). 
According to that study, IgG4-related aortitis was present in 0.5% of all thoracic aorta 
resections. In a subsequent study from Japan, assessment of 125 thoracic aorta resections 
revealed two cases of IgG4-related aortitis, indicating 1.6% of all resected thoracic aortas 
contained IgG4-related aortitis (Khosroshahi et al., 2010).  
Although much remains to be clarified with regard to the pathogenesis of chronic 
periaortitis, it is conceivable that IgG4 may represent a link between chronic periaortitis and 
systemic fibro-inflammatory conditions. The analysis of IgG4-related cases may provide 
additional clues supporting the possible systemic large-vessel involvement in chronic 
periaortitis (Vaglio et al., 2011). 
8. Conclusion 
Chronic periaortitis is a chronic disease characterized by a retroperitoneal 
fibroinflammatory reaction surrounding the abdominal aorta, which may or may not be 
dilated. Although it has been considered a localized inflammatory response to advanced 
atherosclerosis, there is increasing evidence supporting the hypothesis of an underlying 
systemic autoimmune disease with vasculitic process involving small and medium vessels. 
Further studies are warranted in order to elucidate the potential triggers of the disease, the 
pathways leading to the aortic-periaortic inflammation and to the disproportionate 
fibrogenic reaction. 
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